Despite the limitations inherent to spontaneous reporting systems, the results of this FAERS database analyses support the finding that edoxaban prevents renal fibrosis in an experimental mouse model of tubulointerstitial fibrosis and indicate that FXa inhibitors could exert a renoprotective effect in clinical practice. Here, F10 is linked to renal fibrosis.